Zydus Lifesciences Ltd announced an investor presentation detailing its unaudited financial results for Q1 FY26, reporting total revenues of Rs. 65,737 million, a 6% YoY growth, and a net profit of Rs. 14,668 million. The presentation highlights include a stable EBITDA margin of 31.8% and significant growth in international markets.